Perceptive Advisors - ONCOMED PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Perceptive Advisors ownership history of ONCOMED PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$1,787,000
+39.2%
1,719,1110.0%0.05%
+2.0%
Q4 2018$1,284,000
-76.9%
1,719,111
-34.4%
0.05%
-67.1%
Q3 2018$5,556,000
-8.2%
2,620,8970.0%0.15%
-6.3%
Q2 2018$6,054,000
-27.4%
2,620,8970.0%0.16%
-31.8%
Q1 2018$8,334,000
-22.4%
2,620,8970.0%0.23%
-34.6%
Q4 2017$10,745,000
+14.5%
2,620,897
+26.2%
0.36%
+98.9%
Q3 2017$9,386,0002,076,5780.18%
Other shareholders
ONCOMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
ADAMS STREET PARTNERS LLC 1,839,730$41,468,0007.46%
BVF INC/IL 991,433$22,347,0003.81%
Iguana Healthcare Management, LLC 400,000$9,016,0002.97%
APEX CAPITAL, LLC 382,000$8,610,0000.92%
Birchview Capital, LP 58,689$1,323,0000.76%
BRAVE ASSET MANAGEMENT INC 46,550$1,049,0000.71%
HAMILTON LANE ADVISORS LLC 44,376$1,000,0000.44%
NJ State Employees Deferred Compensation Plan 70,000$1,578,0000.32%
Eventide Asset Management 190,000$4,283,0000.21%
DISCIPLINED GROWTH INVESTORS INC /MN 308,600$6,956,0000.18%
View complete list of ONCOMED PHARMACEUTICALS INC shareholders